113 related articles for article (PubMed ID: 31841793)
1. Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial.
Conforti F; Pala L; Pagan E; Bagnardi V; Zagami P; Spaggiari L; Catania C; Vansteenkiste J; Giaccone G; De Pas T
Eur J Cancer; 2020 Jan; 125():94-103. PubMed ID: 31841793
[TBL] [Abstract][Full Text] [Related]
2. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
3. Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer.
Brandt WS; Yan W; Leeman JE; Tan KS; Park BJ; Adusumilli PS; Bott MJ; Molena D; Isbell J; Chaft J; Rimner A; Jones DR
Ann Thorac Surg; 2018 Sep; 106(3):848-855. PubMed ID: 29807005
[TBL] [Abstract][Full Text] [Related]
4. Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.
Reddy JP; Tang C; Shih T; Kim B; Kim C; Nguyen QN; Welsh J; Benveniste M; Zhang J; Liao Z; Gomez DR
Clin Lung Cancer; 2017 Mar; 18(2):141-148. PubMed ID: 27913215
[TBL] [Abstract][Full Text] [Related]
5. Postoperative adjuvant therapy for stage II non-small-cell lung cancer.
Park JH; Shim YM; Baek HJ; Kim MS; Choe DH; Cho KJ; Lee CT; Zo JI
Ann Thorac Surg; 1999 Nov; 68(5):1821-6. PubMed ID: 10585065
[TBL] [Abstract][Full Text] [Related]
6. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.
Senthi S; Lagerwaard FJ; Haasbeek CJ; Slotman BJ; Senan S
Lancet Oncol; 2012 Aug; 13(8):802-9. PubMed ID: 22727222
[TBL] [Abstract][Full Text] [Related]
7. Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study.
Wong ML; McMurry TL; Stukenborg GJ; Francescatti AB; Amato-Martz C; Schumacher JR; Chang GJ; Greenberg CC; Winchester DP; McKellar DP; Walter LC; Kozower BD
Lung Cancer; 2016 Dec; 102():108-117. PubMed ID: 27987578
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
Vansteenkiste JF; Cho BC; Vanakesa T; De Pas T; Zielinski M; Kim MS; Jassem J; Yoshimura M; Dahabreh J; Nakayama H; Havel L; Kondo H; Mitsudomi T; Zarogoulidis K; Gladkov OA; Udud K; Tada H; Hoffman H; Bugge A; Taylor P; Gonzalez EE; Liao ML; He J; Pujol JL; Louahed J; Debois M; Brichard V; Debruyne C; Therasse P; Altorki N
Lancet Oncol; 2016 Jun; 17(6):822-835. PubMed ID: 27132212
[TBL] [Abstract][Full Text] [Related]
9. Differences in patterns of recurrence in early-stage versus locally advanced non-small cell lung cancer.
Lou F; Sima CS; Rusch VW; Jones DR; Huang J
Ann Thorac Surg; 2014 Nov; 98(5):1755-60; discussion 1760-1. PubMed ID: 25110337
[TBL] [Abstract][Full Text] [Related]
10. Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy.
Borghetti P; Barbera F; Bonù ML; Trevisan F; Ciccarelli S; Vitali P; Maddalo M; Triggiani L; Pasinetti N; Pedretti S; Bonetti B; Pariscenti G; Tironi A; Caprioli A; Buglione M; Magrini SM
Radiol Med; 2016 Sep; 121(9):696-703. PubMed ID: 27230669
[TBL] [Abstract][Full Text] [Related]
11. Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLC.
van den Berg LL; Klinkenberg TJ; Groen HJM; Widder J
J Thorac Oncol; 2015 May; 10(5):826-831. PubMed ID: 25629639
[TBL] [Abstract][Full Text] [Related]
12. Comparing the benefits of different radiological follow-up modalities in surgically resected non-small cell lung cancer (NSCLC). A single centre study, Leeds-UK.
Salman DR; Littlejohns DA; Quinn DT; Campbell DC; Robson DJ
Cancer Treat Res Commun; 2020; 25():100252. PubMed ID: 33271495
[TBL] [Abstract][Full Text] [Related]
13. Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC).
Lee SW; Choi EK; Chung WK; Shin KH; Ahn SD; Kim JH; Kim SW; Suh C; Lee JS; Kim WS; Kim DS; Kim DK; Park SI; Sohn KH
Lung Cancer; 2002 Jul; 37(1):65-71. PubMed ID: 12057869
[TBL] [Abstract][Full Text] [Related]
14. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.
Sun B; Brooks ED; Komaki RU; Liao Z; Jeter MD; McAleer MF; Allen PK; Balter PA; Welsh JD; O'Reilly MS; Gomez D; Hahn SM; Roth JA; Mehran RJ; Heymach JV; Chang JY
Cancer; 2017 Aug; 123(16):3031-3039. PubMed ID: 28346656
[TBL] [Abstract][Full Text] [Related]
15. PORTAF - postoperative radiotherapy of non-small cell lung cancer: accelerated versus conventional fractionation - study protocol for a randomized controlled trial.
Bütof R; Simon M; Löck S; Troost EGC; Appold S; Krause M; Baumann M
Trials; 2017 Dec; 18(1):608. PubMed ID: 29262836
[TBL] [Abstract][Full Text] [Related]
16. Detection of Recurrence Patterns After Wedge Resection for Early Stage Lung Cancer: Rationale for Radiologic Follow-Up.
Billè A; Ahmad U; Woo KM; Suzuki K; Adusumilli P; Huang J; Jones DR; Rizk NP
Ann Thorac Surg; 2016 Oct; 102(4):1067-73. PubMed ID: 27345095
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
18. Distant failure after treatment of postoperative locoregional recurrence of non-small cell lung cancer.
Hotta K; Sekine I; Suzuki K; Kondo H; Asamura H; Sumi M; Yamamoto N; Kunitoh H; Ohe Y; Tamura T; Kodama T; Saijo N; Tsuchiya R
Thorac Cardiovasc Surg; 2003 Oct; 51(5):283-7. PubMed ID: 14571346
[TBL] [Abstract][Full Text] [Related]
19. Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC).
Rieber J; Deeg A; Ullrich E; Foerster R; Bischof M; Warth A; Schnabel PA; Muley T; Kappes J; Heussel CP; Welzel T; Thomas M; Steins M; Dienemann H; Debus J; Hoffmann H; Rieken S
Lung Cancer; 2016 Jan; 91():41-7. PubMed ID: 26711933
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer.
Varlotto JM; Recht A; Flickinger JC; Medford-Davis LN; Dyer AM; Decamp MM
Cancer; 2009 Mar; 115(5):1059-69. PubMed ID: 19152440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
